Cell surface sialic acid modulates extracellular matrix adhesion and migration in pancreatic adenocarcinoma cells

Pancreas

Volumn 43, Issue 1, 2014, Pages 109-117

  Bassagañas, Sònia ^a   Pérez Garay, Marta ^a   Peracaula, Rosa ^a  

^a UNIVERSITY OF GIRONA   (Spain)

Author keywords

Adhesion; extracellular matrix; migration; pancreatic adenocarcinoma; sialic acid; sialyltransferases

Indexed keywords

ALPHA 2,3 SIALIC ACID; ALPHA 2,6 SIALIC ACID; CELL SURFACE PROTEIN; CELL SURFACE SIALIC ACID; COLLAGEN TYPE 1; FIBRONECTIN; INTEGRIN; LAMININ; SIALIC ACID DERIVATIVE; SIALYL LEWIS X ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL DENSITY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PANCREAS ADENOCARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; CELL ADHESION; CELL COUNT; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; HUMANS; INTEGRINS; OLIGOSACCHARIDES; PANCREATIC NEOPLASMS; SIALIC ACIDS; SIALYLTRANSFERASES;

EID: 84891556529     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31829d9090     Document Type: Article

References (54)

1. Kleeff J, Beckhove P, Esposito I, et al. Pancreatic cancer microenvironment. Int J Cancer. 2007;121:699-705. (Pubitemid 47106197)
2. Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer. 2005;5:526-542. (Pubitemid 40942829)
3. Varki A, Schauer R. Sialic acids. In: Varki A, Cummings RD, Esko JD, et al, eds. Essentials of Glycobiology. New York, NY: Cold Spring Harbor Laboratory Press; 2009:199-217.
4. Gout S, Tremblay PL, Huot J. Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin Exp Metastasis. 2008;25:335-344. (Pubitemid 351752950)
5. Kannagi R, Izawa M, Koike T, et al. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 2004;95:377-384. (Pubitemid 38832679)
6. Koike T, Kimura N, Miyazaki K, et al. Hypoxia induces adhesion molecules on cancer cells: a missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sci U S A. 2004;101:8132-8137. (Pubitemid 38698066)
7. Buschiazzo A, Alzari PM. Structural insights into sialic acid enzymology. Curr Opin Chem Biol. 2008;12:565-572.
8. Schauer R. Victor Ginsburg's influence on my research of the role of sialic acids in biological recognition. Arch Biochem Biophys. 2004;426:132-141. (Pubitemid 38680610)
9. Harduin-Lepers A, Mollicone R, Delannoy P, et al. The animal sialyltransferases and sialyltransferase-related genes: a phylogenetic approach. Glycobiology. 2005;15:805-817. (Pubitemid 41417983)
10. Chiricolo M, Malagolini N, Bonfiglioli S, et al. Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948. Glycobiology. 2006;16:146-154. (Pubitemid 43125970)
11. Lin S, Kemmner W, Grigull S, et al. Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Exp Cell Res. 2002;276:101-110. (Pubitemid 34948355)
12. Seales EC, Jurado GA, Brunson BA, et al. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res. 2005;65:4645-4652. (Pubitemid 40740800)
13. Shaikh FM, Seales EC, Clem WC, et al. Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms. Exp Cell Res. 2008;314:2941-2950.
14. Hsu CC, Lin TW, Chang WW, et al. Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids. Gynecol Oncol. 2005;96:415-422.
15. Chiang CH, Wang CH, Chang HC, et al. A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling. J Cell Physiol. 2010;223:492-499.
16. Chen JY, Tang YA, Huang SM, et al. A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways. Cancer Res. 2011;71:473-483.
17. Perez-GarayM, Arteta B, Pages L, et al. alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo. PLoS One. 2010;5:pii:e12524.
18. Grzesiak JJ, Bouvet M. The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. Br J Cancer. 2006;94:1311-1319.
19. Christie DR, Shaikh FM, Lucas JAt, et al. ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J Ovarian Res. 2008;1:3.
20. Carvalho AS, Harduin-Lepers A, Magalhaes A, et al. Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. Int J Biochem Cell Biol. 2010;42:80-89.
21. Grzesiak JJ, Ho JC, Moossa AR, et al. The integrin-extracellular matrix axis in pancreatic cancer. Pancreas. 2007;35:293-301. (Pubitemid 350307370)
22. Nakamori S, Kameyama M, Imaoka S, et al. Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis. Dis Colon Rectum. 1997;40:420-431. (Pubitemid 27172619)
23. Portela SV, Martin CV, Romay LM, et al. sLea and sLex expression in colorectal cancer: implications for tumourigenesis and disease prognosis. Histol Histopathol. 2011;26:1305-1316.
24. Vierbuchen MJ, Fruechtnicht W, Brackrock S, et al. Quantitative lectin-histochemical and immunohistochemical studies on the occurrence of alpha(2,3)- and alpha(2,6)-linked sialic acid residues in colorectal carcinomas. Relation to clinicopathologic features. Cancer. 1995;76:727-735.
25. Amado M, Carneiro F, Seixas M, et al. Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology. 1998;114:462-470. (Pubitemid 28141191)
26. Ura H, Denno R, Hirata K, et al. Close correlation between increased sialyl-Lewisx expression and metastasis in human gastric carcinoma. World J Surg. 1997;21:773-776. (Pubitemid 27369122)
27. Wang FL, Cui SX, Sun LP, et al. High expression of alpha 2, 3-linked sialic acid residues is associated with the metastatic potential of human gastric cancer. Cancer Detect Prev. 2009;32:437-443.
28. Cui H, Lin Y, Yue L, et al. Differential expression of the alpha2,3-sialic acid residues in breast cancer is associated with metastatic potential. Oncol Rep. 2011;25:1365-1371.
29. Jeschke U, Mylonas I, Shabani N, et al. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Anticancer Res. 2005;25:1615-1622. (Pubitemid 40896773)
30. Matsuura N, Narita T, Mitsuoka C, et al. Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases. Jpn J Clin Oncol. 1997;27:135-139. (Pubitemid 127516320)
31. Kishimoto T, Ishikura H, Kimura C, et al. Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: the importance of surface sialyl Lewis(a) antigen. Int J Cancer. 1996;69:290-294. (Pubitemid 26298293)
32. Korekane H, Matsumoto A, Ota F, et al. Involvement of ST6Gal I in the biosynthesis of a unique human colon cancer biomarker candidate, alpha2,6-sialylated blood group type 2H (ST2H) antigen. J Biochem. 2010;148:359-370.
33. Dall'Olio F, Chiricolo M, D'Errico A, et al. Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis. Glycobiology. 2004;14:39-49. (Pubitemid 38159407)
34. Yang LP, Jiang S, Liu JQ, et al. Up-regulation of galectin-3 and Sambucus nigra agglutinin binding site is associated with invasion, metastasis and poor-progression of the gallbladder adenocarcinoma. Hepatogastroenterology. 2012;59:2089-2094.
35. Chovanec M, Plzak J, Betka J, et al. Comparative analysis of alpha2,3/2,6-linked N-acetylneuraminic acid and cytokeratin expression in head and neck squamous cell carcinoma. Oncol Rep. 2004; 12:297-301.
36. Lopez-Morales D, Reyes-Leyva J, Santos-Lopez G, et al. Increased expression of sialic acid in cervical biopsies with squamous intraepithelial lesions. Diagn Pathol. 2010;5:74.
37. Wang PH, Lo WL, Hsu CC, et al. Different enzyme activities of sialyltransferases in gynecological cancer cell lines. Eur J Gynaecol Oncol. 2002;23:221-226. (Pubitemid 34625329)
38. Shah MH, Telang SD, Shah PM, et al. Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis. Glycoconj J. 2008;25:279-290.
39. Kim GE, Bae HI, Park HU, et al. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology. 2002;123:1052-1060.
40. Cazet A, Julien S, Bobowski M, et al. Consequences of the expression of sialylated antigens in breast cancer. Carbohydr Res. 2010;345:1377-1383.
41. Ghaneh P, Costello E, Neoptolemos JP. Biology and management of pancreatic cancer. Gut. 2007;56:1134-1152. (Pubitemid 47123247)
42. Taniguchi A, Matsumoto K. Down-regulation of human sialyltransferase gene expression during in vitro human keratinocyte cell line differentiation. Biochem Biophys Res Commun. 1998;243:177-183. (Pubitemid 28414211)
43. Taniguchi A, Higai K, Hasegawa Y, et al. Differentiation elicits negative regulation of human beta-galactoside alpha2,6-sialyltransferase at the mRNA level in the HL-60 cell line. FEBS Lett. 1998;441:191-194. (Pubitemid 29027893)
44. Wen DX, Svensson EC, Paulson JC. Tissue-specific alternative splicing of the beta-galactoside alpha 2,6-sialyltransferase gene. J Biol Chem. 1992;267:2512-2518.
45. Dall'Olio F, Malagolini N, Serafini-Cessi F. The expression of soluble and cell-bound alpha 2,6 sialyltransferase in human colonic carcinoma CaCo-2 cells correlates with the degree of enterocytic differentiation. Biochem Biophys Res Commun. 1992;184:1405-1410.
46. Dall'Olio F, Malagolini N, Guerrini S, et al. Differentiation-dependent expression of human beta-galactoside alpha 2,6-sialyltransferase mRNA in colon carcinoma CaCo-2 cells. Glycoconj J. 1996;13:115-121. (Pubitemid 26074309)
47. Aasheim HC, Aas-Eng DA, Deggerdal A, et al. Cell-specific expression of human beta-galactoside alpha 2,6-sialyltransferase transcripts differing in the 5¶ untranslated region. Eur J Biochem. 1993;213:467-475. (Pubitemid 23106079)
48. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, et al. The human sialyltransferase family. Biochimie. 2001;83:727-737. (Pubitemid 32821237)
49. Taniguchi A. Promoter structure and transcriptional regulation of human beta-galactoside alpha2, 3-sialyltransferase genes. Curr Drug Targets. 2008;9:310-316. (Pubitemid 351836431)
50. Dall'Olio F, Chiricolo M. Sialyltransferases in cancer. Glycoconj J. 2001;18:841-850. (Pubitemid 36315048)
51. Lee M, Park JJ, Lee -S. Adhesion of ST6Gal I-mediated human colon cancer cells to fibronectin contributes to cell survival by integrin beta1-mediated paxillin and AKT activation. Oncol Rep. 2010;23:757-761.
52. Pretzlaff RK, Xue VW, Rowin ME. Sialidase treatment exposes the beta1-integrin active ligand binding site on HL60 cells and increases binding to fibronectin. Cell Adhes Commun. 2000;7:491-500.
53. Semel AC, Seales EC, Singhal A, et al. Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors. J Biol Chem. 2002;277:32830-32836. (Pubitemid 34984793)
54. Chang WW, Yu CY, Lin TW, et al. Soyasaponin I decreases the expression of alpha2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells. Biochem Biophys Res Commun. 2006;341:614-619.